Search research articles
Contact Us
Filters
Showing results (21-30 of 170) with videos related to
Page
of 17
Sort By:
The Journal of Biological Chemistry
|
August 30, 2007
MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta
Amy N Abell, Deborah A Granger, Gary L Johnson
Methods in Enzymology
|
September 19, 2007
Hyperosmotic induction of mitogen-activated protein kinase scaffolding
Thomas L Hilder, Michael H Malone, Gary L Johnson
Molecular & Cellular Oncology
|
December 7, 2017
Enhancer remodeling regulates epigenetic adaptation and resistance to MEK1/2 inhibition in triple-negative breast cancer
Samantha M Bevill, Jon S Zawistowski, Gary L Johnson
Cell Cycle (Georgetown, Tex.)
|
March 14, 2017
Landscaping a chromatin response to MEK inhibition
Jon S Zawistowski, Daniel R Goulet, Gary L Johnson
Genes & Cancer
|
January 4, 2014
MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis
Trang T Pham, Steven P Angus, Gary L Johnson
Molecular & Cellular Oncology
|
June 17, 2016
Epigenetic inhibition of adaptive bypass responses to lapatinib by targeting BET Bromodomains
Timothy J Stuhlmiller, Samantha M Miller, Gary L Johnson
Journal of Cellular Physiology
|
May 18, 2016
Targeting the Breast Cancer Kinome
Samantha M Miller, Daniel R Goulet, Gary L Johnson
Oncoscience
|
August 8, 2017
Pharmacologic targeting of drug-induced enhancers
Jon S Zawistowski, Samantha M Bevill, Gary L Johnson
Biochemical Society Transactions
|
August 12, 2014
Assessing adaptation of the cancer kinome in response to targeted therapies
Jon S Zawistowski, Lee M Graves, Gary L Johnson
Annual Review of Pharmacology and Toxicology
|
September 22, 2017
Epigenetic Mechanisms Regulating Adaptive Responses to Targeted Kinase Inhibitors in Cancer
Steven P Angus, Jon S Zawistowski, Gary L Johnson
Page
of 17
Search research articles
Search
Showing results (21-30 of 170) with videos related to
Sort By:
Page
of 17
The Journal of Biological Chemistry
|
August 30, 2007
MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta
Amy N Abell, Deborah A Granger, Gary L Johnson
Methods in Enzymology
|
September 19, 2007
Hyperosmotic induction of mitogen-activated protein kinase scaffolding
Thomas L Hilder, Michael H Malone, Gary L Johnson
Molecular & Cellular Oncology
|
December 7, 2017
Enhancer remodeling regulates epigenetic adaptation and resistance to MEK1/2 inhibition in triple-negative breast cancer
Samantha M Bevill, Jon S Zawistowski, Gary L Johnson
Cell Cycle (Georgetown, Tex.)
|
March 14, 2017
Landscaping a chromatin response to MEK inhibition
Jon S Zawistowski, Daniel R Goulet, Gary L Johnson
Genes & Cancer
|
January 4, 2014
MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis
Trang T Pham, Steven P Angus, Gary L Johnson
Molecular & Cellular Oncology
|
June 17, 2016
Epigenetic inhibition of adaptive bypass responses to lapatinib by targeting BET Bromodomains
Timothy J Stuhlmiller, Samantha M Miller, Gary L Johnson
Journal of Cellular Physiology
|
May 18, 2016
Targeting the Breast Cancer Kinome
Samantha M Miller, Daniel R Goulet, Gary L Johnson
Oncoscience
|
August 8, 2017
Pharmacologic targeting of drug-induced enhancers
Jon S Zawistowski, Samantha M Bevill, Gary L Johnson
Biochemical Society Transactions
|
August 12, 2014
Assessing adaptation of the cancer kinome in response to targeted therapies
Jon S Zawistowski, Lee M Graves, Gary L Johnson
Annual Review of Pharmacology and Toxicology
|
September 22, 2017
Epigenetic Mechanisms Regulating Adaptive Responses to Targeted Kinase Inhibitors in Cancer
Steven P Angus, Jon S Zawistowski, Gary L Johnson
Page
of 17